Cancer cells expressing PD-1 showed synergistic enhancement of therapeutic effect in subcutaneous and lung metastasis models of breast cancer, blocking the function of immune checkpoint PD-1/PD-L1 ligand and activated T cells [163]. Here, PDCD1 is linked to breast carcinoma.